tiprankstipranks
Trending News
More News >
Biosyent Inc (TSE:RX)
:RX
Canadian Market

Biosyent (RX) Revenue

Compare
45 Followers

Biosyent Revenue

Biosyent had a revenue of 9.56M in the quarter ending Sep 30, 2024, with 6.84%. This bring the company's revenue in the last twelve months to 34.51M, Decreased 2.02%. In the fiscal year ending Dec 31, 2023, Biosyent had annual revenue of 31.59M with 13.12% growth.
Revenue (ttm)
34.51M
Revenue Growth
10.89%
P/S Ratio
3.74
Revenue/Employee
Employees
Market Cap
C$118.04M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202331.59M3.67M+13.12%
Dec 31, 202227.93M-693.03K-2.42%
Dec 31, 202128.62M6.29M+28.15%
Dec 31, 202022.33M907.84K+4.24%
Dec 31, 201921.42M-102.70K-0.48%
Dec 31, 201821.53M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis